Overview

A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations

Status:
COMPLETED
Trial end date:
2025-07-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the relative bioavailability of a single dose AZD5004 in healthy participants, among 3 different oral tablet formulations.
Phase:
PHASE1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Parexel